EGFR mediates epithelial‑mesenchymal transition through the Akt/GSK-3β/Snail signaling pathway to promote liver cancer proliferation and migration-Reference-Cited by-同舟云学术

EGFR mediates epithelial‑mesenchymal transition through the Akt/GSK-3β/Snail signaling pathway to promote liver cancer proliferation and migration

Published:2023-12-18 Issue:2 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Gao Jiafeng¹,Huo Zhen¹,Song Xueyi¹,Shao Qianqian¹,Ren Weiwei²,Huang Xiaolong²,Zhou Shuping²,Tang Xiaolong¹

Affiliation:

1. Medical School, Anhui University of Science & Technology, Huainan, Anhui 232001, P.R. China

2. Department of Gastroenterology and Hepatology, Huainan First People's Hospital and First Affiliated Hospital of Anhui University of Science & Technology, Huainan, Anhui 232001, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference36 articles.

1. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators;Fujimoto;Nat Genet,2012

2. Identification of potential microRNA groups for the diagnosis of hepatocellular carcinoma (HCC) using microarray datasets and bioinformatics tools;Dat;Heliyon,2022

3. An overview of hepatocellular carcinoma after insufficient radiofrequency ablation;Guo;J Hepatocell Carcinoma,2022

4. NASH limits anti-tumour surveillance in immunotherapy-treated HCC;Pfister;Nature,2021

5. Metastasis: A therapeutic target for cancer;Steeg;Nat Clin Pract Oncol,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancements in the small-molecule drugs for hepatocellular carcinoma (HCC): Structure-activity relationships, pharmacological activities, and the clinical trials;Biomedicine & Pharmacotherapy;2024-10

2. Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets;MedComm;2024-08

3. Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets;Cancers;2024-02-23